Form 8-K - Current report:
SEC Accession No. 0001193125-25-269538
Filing Date
2025-11-06
Accepted
2025-11-06 16:12:42
Documents
11
Period of Report
2025-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imnm-20251106.htm   iXBRL 8-K 54213
2 EX-99.1 imnm-ex99_1.htm EX-99.1 132841
  Complete submission text file 0001193125-25-269538.txt   365111

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT imnm-20251106.xsd EX-101.SCH 61492
13 EXTRACTED XBRL INSTANCE DOCUMENT imnm-20251106_htm.xml XML 4706
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 251458415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)